Physician profile
Anas Hashem
NPI 1952970923
$1,610.57
in general payments reported to CMS, 2019-2025
11 companies · $1,611 in 2025
The $1,611 reported for 2025 was more than what 96% of Hospitalist providers received nationally (typical 2025 total: $85.87).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2025: $1,611.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,611.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,610.57 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $357.27 | 2025 | Mitraclip, Diamondback Coronary, Cardiomems |
| Cardiva Medical, INC. | $198.95 | 2025 | Cardiva Vascade 6/7f Vcs, Cardiva Vascade 5f Vcs, Cardiva Vascade Mvp Vvcs 6-12f |
| Bridgebio Pharma, INC. | $194.35 | 2025 | Attruby |
| Medtronic, INC. | $193.50 | 2025 | Corevalve Evolut R, Cobalt Dr Mri Surescan |
| Boston Scientific Corporation | $162.78 | 2025 | General - Balloon Catheters |
| Edwards Lifesciences Corporation | $158.86 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $139.27 | 2025 | Wainua |
| Abiomed | $87.18 | 2025 | |
| Amgen INC. | $56.04 | 2025 | Repatha |
| Biotronik INC. | $37.83 | 2025 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $24.54 | 2025 | Lifevest |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Anas Hashem listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.